Google's life sciences sister plugs Big Pharma into the mainstream in a digital overhaul of the clinical trial business
Can the globally influential Google revolutionize the multibillion-dollar clinical trial business?
Some of the biggest pharmas out there think so, looking to Google’s sister outfit Verily — operating under Alphabet, the parent company — to guide the industry into the digital age with its extraordinary reach into the lives of billions of people on the planet.
This morning, Novartis, Pfizer, Sanofi and Otsuka all lined up to jump on the Project Baseline platform at the Google-related life sciences division, looking to employ the digital Goliath’s tech services in recruiting patients and organizing the mass of data coming out of the global trial system.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.